Dr. Jactel was appointed as Chief Executive Officer (CEO) in January, 2013. He spent 12 years at Merial Limited, the US$2.6 billion revenue generating Animal Health subsidiary of the Sanofi Group, most recently as combined Chief Strategy Officer and Chief Marketing Officer. As Head of commercial operations in Europe, Dr. Jactel developed successful growth strategies in both OTC and professional channels. He was further responsible for global marketing, brand management, enterprise and franchise strategy, in addition to being a co-chair on the R&D steering committee. During this time, Merial built the most successful consumer brand in animal health history with FRONTLINE (Flea and tick product for pets) reaching $1billion in annual revenue in 2009.
Before working at Merial, Dr. Jactel was Deputy Minister for Economic and Commercial Affairs at the French Embassy in Washington D.C. Prior to that, he was Assistant Professor at National Veterinary School of Alfort, Paris. He is also a recent founder and board member of Hypercell Technologies LLC, an early-stage biotech company developing therapeutic solutions to serious infectious animal diseases. Dr. Jactel is a Doctor of Veterinary Medicine and has a Masters in Economic Sciences from the Sorbonne University in Paris.
He is a member of the Board of Advisors of the Raleigh Chamber of Commerce and is a Board member of the Veterinary School in Paris.